期刊
BONE MARROW TRANSPLANTATION
卷 26, 期 10, 页码 1107-1109出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bmt.1702664
关键词
melphalan-associated pulmonary toxicity; cyclophosphamide-associated pulmonary toxicity; diffuse interstitial pneumonitis; high-dose therapy; autologous hematopoietic stem cell transplant
Melphalan can rarely cause interstitial pneumonitis and fibrosis, Although it has been reported previously in patients after conventional doses, we report four cases developing diffuse interstitial pneumonitis (DIP) after high-dose melphalan-based therapy. In a 3-year period, four of 57 (7%) consecutive patients undergoing high-dose melphalan (200 mg/m(2); MEL 200) were identified with DIP. Two patients who were heavily pre-treated with alkylators developed progressive respiratory failure despite high-dose steroids and eventually died. The other two patients previously treated with vincristine, adriamycin, and dexamethasone (VAD) improved dramatically on high-dose steroids with complete resolution of their pneumonitis. Melphalan should be added to the growing list of alkylators causing pulmonary toxicity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据